Atlas Trials

Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain

Clinical trial NCT02046434 · COMPLETED

Trial details

NCT number
NCT02046434
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2014-01-01
Primary completion
2019-09-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.